Knowledge Center · Peptides
Every peptide gets the same honest treatment: what it is, how it's proposed to work, the real strength of the evidence, what we don't know, and the questions to bring to a licensed provider. Education only.
BPC-157 is a synthetic peptide studied primarily in animals for its proposed effects on tissue repair. Interest is high, but the evidence base is largely preclinical — meaningful human clinical trial data is limited.
TB-500 is a synthetic fragment related to Thymosin Beta-4, studied in animals for actin regulation, cell migration, and tissue repair. Human clinical evidence is limited.
GHK-Cu is a naturally occurring copper-binding tripeptide studied for skin and tissue, with the most human evidence in topical cosmetic applications.
CJC-1295 is a synthetic growth-hormone-releasing hormone (GHRH) analog studied for its ability to raise growth hormone and IGF-1. Human data is limited; it is not FDA-approved.
Ipamorelin is a synthetic, selective growth-hormone secretagogue (a ghrelin-receptor agonist) studied for stimulating GH release with relatively few off-target hormonal effects.
GHRH analog with an approved indication; research interest beyond it.
GHRH analog historically used in growth-hormone research.
Mitochondrial-derived peptide studied in metabolism (preclinical).
Mitochondria-targeted peptide (elamipretide) in research.
Studied in longevity and telomere research (preclinical).
Growth-hormone fragment studied in metabolic research.
Immune-modulating peptide with clinical research history.
Parent peptide of TB-500; repair and cytoprotection research.
Bremelanotide; melanocortin-receptor agonist research.
Upstream regulator of reproductive hormone signaling.
More peptides are added on the same template. Each page is written conservatively and updated as evidence evolves.
If you'd like help applying this information to your own health, schedule a consultation with the Bearing team.